Skip to main content
SMS Pharmaceuticals Ltd logo

SMS Pharmaceuticals Ltd — Investor Relations & Filings

Ticker · SMSPHARMA ISIN · INE812G01025 LEI · 335800XXEADQCB7GJ514 BSE.NS Manufacturing
Open in API
Filings indexed 745 across all filing types
Latest filing 2026-05-23 Investor Presentation
Country IN India
Listing BSE.NS SMSPHARMA

About SMS Pharmaceuticals Ltd

https://smspharma.com/

SMS Pharmaceuticals Ltd specializes in the development and large-scale manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. The organization operates multiple manufacturing units and research centers, maintaining compliance with international regulatory standards including USFDA approvals. Its core product portfolio covers therapeutic areas such as anti-ulcerants, anti-migraine agents, anti-hypertensives, and anti-retrovirals. Beyond its proprietary product line, the company provides Contract Research and Manufacturing Services (CRAMS), offering expertise in process development, chemical synthesis, and analytical validation. The company focuses on delivering high-quality chemical solutions through integrated research and development capabilities, supporting global supply chains with a commitment to technical excellence and operational efficiency.

Recent filings

Filing Released Lang Actions
General Updates
Investor Presentation Classification · 95% confidence The document is an investor presentation slide deck provided under Regulation 30, including Safe Harbour slides, financial highlights (Q4 & FY26), company overview, strategy, and historical P&L tables. This matches the definition for an Investor Presentation (Code: IP).
2026-05-23 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is a detailed slide deck titled “Investor Presentation” sent to stock exchanges under SEBI Listing Obligations for the quarter and year ended March 31, 2026. It contains financial highlights, strategy, performance review, and forward-looking statements typical of an investor presentation rather than an annual report or earnings release. Hence, it should be classified as an Investor Presentation.
2026-05-23 English
Press Release on Financial Results for the year ended 31.03.2026
Earnings Release Classification · 90% confidence The document is a press release submitted to stock exchanges announcing the audited financial results for the quarter and full year ended March 31, 2026. It provides key financial highlights (PAT, EBITDA margins, revenue growth), a summary table of results by period, and management commentary—characteristic of an earnings release. It is not a full annual or interim report, nor a regulatory filing announcement or certification. Therefore, it matches the definition of an Earnings Release (ER). FY 2026
2026-05-23 English
Press Release
Earnings Release Classification · 93% confidence The document is a corporate press release announcing audited financial results for the quarter and full year ended March 31, 2026. It provides key performance highlights (revenue, EBITDA, PAT, margins), segmental tables, management commentary, outlook, and dividend declaration. This aligns with an Earnings Release (initial announcement of periodical financial results), not a full annual or interim report filing. FY 2026
2026-05-23 English
Intimation of Investor Call
Regulatory Filings Classification · 95% confidence The document is a formal intimation under SEBI LODR Regulation 30 notifying stock exchanges of an upcoming investor conference call to discuss financial results. It does not contain the financial data itself (so not an earnings release or report), nor is it a transcript, presentation deck, or management discussion. It is a regulatory announcement/falling under miscellaneous compliance disclosures. Therefore, it best fits the Regulatory Filings (RNS) category.
2026-05-22 English
Analysts/Institutional Investor Meet/Con. Call Updates
Report Publication Announcement Classification · 85% confidence The document is a notice under SEBI LODR Regulation 30 announcing an investor conference call and stating that the company’s Q4 & FY26 financial results have been published on its website. It contains no actual financial data or detailed results—only an invitation and a link to the published report. Per the “menu vs. meal” rule, this is an announcement of report publication rather than the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-05-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.